Skip to content
Issue Areas
Events
Publications
Connect With Us
About Us
About IHP
Meet the Team
Contributing Authors
Search
Menu
Open mobile menu
Close mobile menu
Search
Drug Policy
Research Round Up: Biosimilar Medications are Safe and Effective
Biosimilars at Kaiser Permanente: Lessons in successfully reducing spending on prescription drugs
Want to lower drug prices? Reform the U.S. patent system
Preserving and bolstering the necessary tools to promote insulin affordability
Publications from PORTAL
Restoring Provider Confidence In FDA-Approved Drugs
Evolving nature of evidence required by FDA to approve new drugs
Drug policy 101: Kaiser Permanente’s Approach to Pharmaceutical Detailing
Building a bigger table for a more equitable drug development system
The Medicaid Drug Rebate Program and the impact of “best price” rules
Load More
Back To Top
Search